UK'S NICE REJECTS TWO NEW BOWEL CANCER DRUGS

Two new targeted therapies for bowel cancer should not be used on Britain's state-run health service, the country's cost-effectiveness watchdog NICE said on Monday.

Scientific American (http://www.sciam.com/article.cfm?chanID=sa003&articleID=043C2EC6C6390DD0AC5519190A57C88C)